| 1/39 | US=4 / Cirurgia Sharkey RM, Goldenberg DM. Antibodies and their conjugates for the targeted therapy of cancer. In: Silberman H, Silberman AW. Principles and practice of surgical oncology: a multidisciplinary approach to difficult problems. Philadelphia: J B Lippincott, 2010. p. 116-36. ISBN 978-0-7817-6546-6. CANCER; ONCOLOGIA CIRURGICA; TERAPIA-ALVO; ANTICORPOS; ANTICORPOS NAO-CONJUGADOS; IMUNOCONJUGADOS; RADIONUCLIDEOS; DROGAS IMUNOCONJUGADAS; TOXINAS IMUNOCONJUGADAS |
| 2/39 | US=11 / Cab/Pesc Kies MS. Principles of chemotherapy. In: Neligan PC, Wei FC. Microsurgical reconstruction of the Head and Neck. St Louis: QMP, 2010. p. 53-76. CANCER DE CABECA E PESCOCO; QUIMIOTERAPIA; CARCINOMA DE CELULAS ESCAMOSAS; TERAPIA COMBINADA; QUIMIOIRRADIACAO; QUIMIOTERAPIA DE INDUCAO; QUMIOTERAPIA SISTEMICA; TERAPIA-ALVO |
| 3/39 | US=5 / Gastro Kim E, Zalupski MM. Systemic therapies for advanced hepatocellular carcinoma: review of current status of chemotherapy for the treatment of hepatocellular carcinoma. In: Hussain HK, Francis IR. Primary carcinomas of the liver. New York: Cambridge University Press, 2010. p. 113-21. (Contemporary issues in cancer imaging) ISBN 978-0-524-51951-9. CANCER DE FIGADO; CARCINOMA HEPATOCELULAR; CARCINOMA HEPATOCELULAR. TRATAMENTO NAO-CIRURGICO; CARCINOMA HEPATOCELULAR. ESTAGIO AVANCADO; QUIMIOTERAPIA; AGENTES CITOTOXICOS; BIOTERAPIA; TERAPIA-ALVO |
| 4/39 | US=5 / Gastro Khan GN, Zalupski MM. Treatment of cholangiocarcinoma: non-surgical treatment - systemic therapy. In: Hussain HK, Francis IR. Primary carcinomas of the liver. New York: Cambridge University Press, 2010. p. 206-213. (Contemporary issues in cancer imaging) ISBN 978-0-524-51951-9. CANCER DE FIGADO; CARCINOMA HEPATOCELULAR; COLANGIOCARCINOMA; COLANGIOCARCINOMA. TRATAMENTO NAO-CIRURGICO; TERAPIA SISTEMICA; QUIMIOTERAPIA; FLUOROPIRIMIDINA; GEMCITABINA; TERAPIA-ALVO |
| 5/39 | US=22 / Urologia Jonasch E, Walker CL. EGFR and HER2: relevance in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 287-303. ISBN 978-1-58829-737-2. CARCINOMA DE CELULAS RENAIS; ERBB; TERAPIA-ALVO; RESISTENCIA; SINALIZACAO |
| 6/39 | US=33 / Câncer Cheng L, Zbang S, Davidson DD, Montironi R, Lopez-Beltran A. Implications of cancer stem cells for cancer therapy. In: Bagley RG, Teicher BA. Stem cells and cancer. New York: Humana Press, 2009. p. 255-62. ISBN 978-1-60327-932-1. CELULAS-TRONCO DO CANCER; VIA DE SEGMENTACAO; TERAPIA-ALVO; MEDICINA PERSONALIZADA; CELULA-TRONCO MESENQUIMAL; BIOLOGIA ESTROMAL |
| 7/39 | US=44 / Biol/Mol Stewart FM, Stewart JA. Diagnosis and treatment of malignant diseases. In: Pardee AB, Stein GS, editors. The biology and treatment of cancer: understanding cancer. New Jersey: John Wiley & Sons, 2009. p. 57-81. ISBN 978-0-470-00958-1. DOENCAS MALIGNAS. DIAGNOSTICO; DOENCAS MALIGNAS. TRATAMENTO; CIRURGIA ROBOTICA; TERAPIA DE RADIACAO; PROTON TERAPIA; TERAPIA MEDICAMENTOSA; TERAPIA-ALVO; CUIDADOS PALIATIVOS; MEDICINA INTEGRATIVA |
| 8/39 | US=50 / Câncer Berz D, McCormack E, Mega A, Wanebo HJ. Targeting signaling pathways in cancer therapy. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 309-26. ISBN 978-1-60327-086-1. EGFR; RECEPTOR DO FATOR DE CRESCIMENTO EPITELIAL; INIBIDORES DA QUINASE DE TIROSINA; MOLECULAS PEQUENAS; SOLIDAS MALIGNAS DE TUMORES; TERAPIA-ALVO; PREDITORES DE RESPOSTA; CANCER DE MAMA; CARCINOMA HEPATOCELULAR; CANCER DE PULMAO; CANCER DE COLON |
| 9/39 | US=50 / Câncer Rugo HS, Lin AYJ. Targeted therapy for breast cancer: a focus on HER2/neu and antiangiogenic therapy. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 497-509. ISBN 978-1-60327-086-1. TERAPIA-ALVO PARA CANCER DE MAMA; HER2/NEU E TERAPIA ANTIANGIOGENICA; CANCER DE MAMA METASTATICO; HER2/NEU; TRASTUZUMAB; LAPATINIB; BEVACIZUMAB; SUNITINIB; ANTIANGIOGENICO; TERAPIA-ALVO |
| 10/39 | US=97 / Biol/Mol Song S, Dent P, Grant S. The impact of molecularly targeted in multi-modality therapy. In: Molls M, Vaupel P, Nieder C, Anscher MS. The impact of tumor biology on cancer treatment and multidisciplinary strategies. Baltimore: Springer, 2009. p. 191-219. (Medical Radiology Radiation Oncology) ISBN 978-3-540-74385-9. CANCER; MULTI-TERAPIA; CLASSES DE AGENTES DE TERAPIA ESPECIFICA; TERAPIA-ALVO DE MALIGNIDADES COMUNS; RADIACAO; TERAPIA-ALVO; TERAPIAS CONVENCIONAIS |
| 11/39 | US=28 / Biol/Mol Gordon MS, Ebbinghaus SW. Antiangiogenic therapy of renal cell carcinoma. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 427-39. ISBN 978-1-58829-870-6. CARCINOMA DE CELULAS RENAIS; CANCER DE RIM; ANTI ANGIOGENICA; TERAPIA-ALVO |
| 12/39 | US=23 / Câncer Frasci G, D'Aiuto G, Iodice G, D'Aiuto M, Comella G. Locally advanced breast cancer: role of chemotherapy in improving prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 327-49. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA LOCALMENTE AVANCADO; QUIMIOTERAPIA; QUIMIOTERAPIA PRE-OPERATORIA; QUIMIOTERAPIA POS-OPERATORIA; TRATAMENTO NEOADJUVANTE; TERAPIA-ALVO |
| 13/39 | US=33 / Gastro Kelsen DP, Van De Velde CJH, Minsky BD. Gastric cancer: clinical management. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 285-316. ISBN 978-0-7817-7617-2. CANCER GASTRICO; TRATAMENTO CLINICO; TRATAMENTO CIRURGICO; TERAPIA ADJUVANTE; IMUNOQUIMIOTERAPIA; QUIMIOTERAPIA NEOADJUVANTE; TERAPIA-ALVO |
| 14/39 | US=64 / Câncer Heffner LT. Staging in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 3-7. (Comtemporary Hematology) ISBN 978-1-934115-82-4. MIELOMA MULTIPLO; TERAPIA-ALVO; MEDICINA TRADUCAO; BIOINFORMATICA; ACIDO TRANS-RETINOICO; GIST; IMATINIB; DASATINIBE; EPIGENETICA; DECITABINA; DETER HIPOTESE CELULAR |
| 15/39 | US=67 / Biol/Mol Wadler S. Molecular targeting in upper gastrointestinal malignancies. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 117-31. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. NEOPLASIAS GASTROINTESTINAIS SUPERIORES; SEGMENTACAO MOLECULAR; CARCINOMA HEPATOCELULAR; CANCER DE PANCREAS; CANCER DE ESTOMAGO; TERAPIA-ALVO |
| 16/39 | US=67 / Biol/Mol Ho C, Davies AM, Lara PN, Gautschi O, Mach PC, Gumerlock PH, Gandara DR. Untargeted use of targeted therapy: a dilemma in non-small cell lung cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 227-40. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; TERAPIA-ALVO; EGFR; VEGF; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FATOR DE CRESCIMENTO VASCULAR ENDOTELIAL |
| 17/39 | US=67 / Biol/Mol Heath EI, Carducci MA. Targeted therapies for prostate cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 263-90. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER DE PROSTATA; TERAPIA-ALVO; INIBIDORES DA VIA DE SINALIZACAO; INIBIDORES DA ANGIOGENESE; IMUNOTERAPIA; AGENTES ANTI-TUBULINA; AGENTES ANTI-MITOTICOS; AGENTES DE SEGMENTACAO ANTI-VASCULARES |
| 18/39 | US=67 / Biol/Mol Atieh DM, Vahdat LT. Targeted therapy for beast cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 309-42. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER DE MAMA; TERAPIA-ALVO; TRASTUZUMABE; HER-2; MICROARRAY; BEVACIZUMABE; VEGF; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; LAPATINIBE; ANTICORPOS MONOCLONAIS; INIBIDOR DA TIROSINA QUINASE |
| 19/39 | US=67 / Biol/Mol Nakamura T, Russell SJ. Engineering oncolytic measles viruses for targeted cancer therapy. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 431-45. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. VIRUS ONCOLITICOS; SARAMPO; TERAPIA DE CANCER; TERAPIA-ALVO; VIROTERAPIA |
| 20/39 | US=67 / Biol/Mol Dy GK, Adjei AA. Patient selection for rational development of novel anticancer agents. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 641-8. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. AGENTES ANTICANCERIGENOS; SELECAO DOS PACIENTES; TERAPIA-ALVO; BIOMARCADORES; EXPRESSAO GENICA; AMPLIFICACAO GENICA |